The Patent Finder

PR Pharmaceuticals, Inc.

Also on record
Records under this name other than patents PR Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 8 of 8 · Back to PR Pharmaceuticals, Inc.

PatentTitleStatus Expires Confidence
US 8,916,196Method for the production of emulsion-based microparticles
Formerly held
In force
 · High confidence
In forceHigh confidence
US 8,871,269Method for the preparation of controlled release formulations
Formerly held
In force
 · High confidence
In forceHigh confidence
US 8,900,636Controlled release compositions
Formerly held
In force
 · High confidence
In forceHigh confidence
US 9,040,664Materials and Methods for Preparing Protein-Polymer Conjugates
Formerly held
Lapsed on the fee record
Ended May 26, 2023 · High confidence
Lapsed on the fee recordEnded May 26, 2023High confidence
US 6,720,008Composition and Method for the Encapsulation of Water-Soluble Molecules into Nanoparticles
Formerly held
Term ended
Term ended Jul 4, 2022 · High confidence
Term endedTerm ended Jul 4, 2022High confidence
US 6,706,289Methods and Compositions for Enhanced Delivery of Bioactive Molecules
Formerly held
Term ended
Term ended Oct 31, 2021 · High confidence
Term endedTerm ended Oct 31, 2021High confidence
US PP14,749Chrysanthemum plant named ‘MN90-275-27’
Formerly held
Term ended
Term ended Oct 30, 2021 · From the USPTO record
Term endedTerm ended Oct 30, 2021From the USPTO record
US 9,662,371Treatment of autism and similar disorders
Formerly held
Lapsed on the fee record
Ended May 30, 2021 · From the USPTO record
Lapsed on the fee recordEnded May 30, 2021From the USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited